Categories: News

World Hemophilia Day 2026 – April 17, 2026 – “Diagnosis: First step to care.”

MONTREAL, April 17, 2026 /PRNewswire/ — On April 17, 2026, the global inherited bleeding disorders community will come together on World Hemophilia Day to advocate for all inherited bleeding disorders. This year’s theme of “Diagnosis: First step to care” highlights the critical importance of diagnosis—the essential first step in treatment and care. The WFH estimates that over three-quarters of the population of people with hemophilia worldwide are undiagnosed, and an even more significant gap also exists for other bleeding disorders. This means that hundreds of thousands of people around the world still lack access to basic care. We have the power—and the shared commitment—to change this. We can improve diagnostic outcomes by strengthening the skills of healthcare professionals and enhancing the effectiveness of laboratories. By increasing global diagnosis rates, we can move one step closer to our shared vision of Treatment for All.   

- Advertisement -

#WHD2026       wfh.org/whd

- Advertisement -

“Accurate diagnosis is the gateway to care for people living with bleeding disorders. Yet in many parts of the world, barriers continue to delay or prevent proper diagnosis—leading to unacceptably low diagnosis rates. The challenge is even greater for people with von Willebrand disease, rare bleeding disorders, and for women and girls with bleeding disorders. On April 17, I call on the global community to unite in advocating for stronger diagnostic capabilities everywhere—because without diagnosis, there is no treatment, and without treatment, there is no progress.”
—Cesar Garrido, WFH President

- Advertisement -

World Hemophilia Day 2026 calls on governments, healthcare providers, and advocates around the world to take meaningful action to close the gap in diagnosing people with bleeding disorders. In many regions—and across several types of bleeding disorders—diagnosis is often delayed, leaving individuals without the treatment and care they urgently need. These delays can significantly impact health, quality of life, and long-term outcomes. By working together, we can confront these inequities and ensure that every person with a bleeding disorder receives a timely diagnosis—the first critical step toward access to care.

- Advertisement -

World Hemophilia Day is an opportunity for individuals, organizations, and communities to come together and make a difference. Here are some ways to participate:

- Advertisement -
  • Contact your national patient association to find out how you and other members can work together on World Hemophilia Day and raise awareness for increasing diagnosis of bleeding disorders.
  • Participate in the World Hemophilia Day Light it Up Red! campaign. Last year, thousands of people worldwide showed their support by lighting up over 175 landmarks red in cities across the world
  • Support our global advocacy efforts and be a part of what we are building today for future generations by donating here
  • Share your story about how your quality of life—or the quality of life of someone you know—has changed thanks to receiving a diagnosis, treatment and care on wfh.org/whd
  • Get social by posting about inherited bleeding disorders on Facebook, X, LinkedIn and Instagram using the #WorldHemophiliaDay, #WHD2026 and #LightItUpRed hashtags
  • Download resources like posters and social media banners from wfh.org/whd to help build your World Hemophilia Day Campaign
  • Take action locally and use WFH World Hemophilia Day materials to send a letter to your local policymakers, set up meetings with elected officials and health ministers and engage with the local media
  • Follow the WFH on our social channels and share our World Hemophilia Day content with the world

To learn more about World Hemophilia Day, please visit wfh.org/world-hemophilia-day.

- Advertisement -

The WFH would like to thank our World Hemophilia Day sponsors for their continued support: Bayer, BioMarin Pharmaceutical Inc., CSL Behring, F. Hoffman-La Roche Ltd., Grifols, Kedrion, LFB S.A, Novo Nordisk, Octapharma, Pfizer, Regeneron, Sanofi, Sobi, and Takeda.

- Advertisement -

About hemophilia and other bleeding disorders

- Advertisement -

In people with bleeding disorders, the blood clotting process doesn’t work properly, with the result that they can bleed for longer than normal, and some people may experience spontaneous bleeding into joints, muscles, or other parts of their bodies which can lead to developmental and permanent mobility issues.

- Advertisement -

About the World Federation of Hemophilia

- Advertisement -

The World Federation of Hemophilia (WFH) is a non-profit organization dedicated to improving and sustaining care for people with inherited bleeding disorders around the world. At the WFH, national member organizations (NMOs) and health care professionals (HCPs) work together to provide care for people with inherited bleeding disorders around the world. We partner with governments and hemophilia treatment centres to enhance knowledge through training and provide tools they need to identify, support, and treat people living with bleeding disorders in their communities, while promoting global advocacy and collaboration to achieve our common goals. The WFH is founded upon the following core values and organizational principles: patients first, collaboration, integrity, respect, solidarity and excellence.

- Advertisement -

Our vision of Treatment for All is for a world where all people with inherited bleeding disorders have access to care, regardless of their type of bleeding disorder, gender, age, or where they live. Our mission is to improve and sustain care for people with inherited bleeding disorders around the world.

- Advertisement -

To find out more about the WFH, please visit www.wfh.org.

- Advertisement -

Media contact: Neha Suchak, Director, Marketing & Communications, nsuchak@wfh.org, +1 514-875-7944, #2857

- Advertisement -

Logo – https://mma.prnewswire.com/media/2953328/World_Federation_of_Hemophilia_World_Hemophilia_Day_2026___April.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/world-hemophilia-day-2026—april-17-2026—diagnosis-first-step-to-care-302738741.html

- Advertisement -

Recent Posts

argenx to Host Myositis R&D Webinar on June 23, 2026

May 28, 2026 01:00 ET  | Source: argenx SE May 28, 2026Amsterdam, the Netherlands –…

1 hour ago

Press Release: Sanofis venglustat accepted for priority review in the US to treat type 3 Gaucher disease

Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease…

1 hour ago

Memora Supplement Under Investigation: Effective Brain Booster Formula Against EMF Radiation – Latest Memory Health Report

New York, NY, May 27, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated…

1 hour ago

GIGABYTE Brings ENTER INFINITY to COMPUTEX 2026, Previewing Its AI Ecosystem and Immersive Computing Experiences

TAIPEI, May 28, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, announced its participation…

1 hour ago

TestMu AI Expands KaneAI With Enhanced Test Authoring and Advanced Recording Capabilities

The latest KaneAI enhancements introduce smarter interaction recording, advanced click actions, intelligent failure recovery, and…

1 hour ago

Compal and GMI Cloud Announce Collaboration on AI Infrastructure Development

TAIPEI, May 27, 2026 /PRNewswire/ -- Compal Electronics Inc. ("Compal"; TWSE: 2324) today announced its…

1 hour ago